Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimal islet transplantation in new-onset type 1 diabetes
2014-004110-28Phase 2Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of antithymocyte globulin rabbit, pegfilgrastim and sirolimus in diabetes mellitus type 1 (T1D), sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Change from baseline in insulin secretory response (C-peptide AUC during MMTT). Started Dec 2014; status: completed.
02
Drugs
antithymocyte globulin rabbitpegfilgrastimsirolimus
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2014-004110-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004110-28.